Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Breccia

Showing results (81-90 of 427) with videos related to

Pageof 43
Sort By:
Haematologica|October 18, 2006
Identification of risk factors in atypical chronic myeloid leukemiaMassimo Breccia, Francesca Biondo, Roberto Latagliata, et al.
JMIR Research Protocols|April 23, 2021
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational StudyFabio Efficace, Massimo Breccia, Paola Fazi, et al.
Frontiers in Cell and Developmental Biology|March 16, 2026
Molecular characterization of pediatric mastocytosis revealed different somatic mutations with uncertain prognostic valueDeborah Kasmi, Fiorina Giona, Michela Ribersani, et al.
Expert Review of Hematology|June 14, 2021
Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature reviewFabio Efficace, Laura Cannella, Massimo Breccia, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 7, 2023
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New CompoundsEmilia Scalzulli, Ida Carmosino, Alessandro Costa, et al.
Seminars in Oncology|November 22, 2019
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology<sup>☆</sup>Massimo Breccia, Joseph R Carver, Sebastian Szmit, et al.
Oncology and Therapy|January 17, 2025
Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with RuxolitinibAlessandro Laganà, Emilia Scalzulli, Ida Carmosino, et al.
Critical Reviews in Oncology/Hematology|February 3, 2016
Do the smoking intensity and duration, the years since quitting, the methodological quality and the year of publication of the studies affect the results of the meta-analysis on cigarette smoking and Acute Myeloid Leukemia (AML) in adults?Vittoria Colamesta, Silvia D'Aguanno, Massimo Breccia, et al.
Expert Review of Hematology|December 8, 2024
Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in Chronic myeloid leukemia (CML)Alessandro Laganà, Emilia Scalzulli, Maria Laura Bisegna, et al.
Haematologica|September 5, 2007
Sustained molecular remission after low dose gemtuzumab-ozogamicin in elderly patients with advanced acute promyelocytic leukemiaMassimo Breccia, Giuseppe Cimino, Daniela Diverio, et al.
Pageof 43

Showing results (81-90 of 427) with videos related to

Sort By:
Pageof 43
Haematologica|October 18, 2006
Identification of risk factors in atypical chronic myeloid leukemiaMassimo Breccia, Francesca Biondo, Roberto Latagliata, et al.
JMIR Research Protocols|April 23, 2021
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational StudyFabio Efficace, Massimo Breccia, Paola Fazi, et al.
Frontiers in Cell and Developmental Biology|March 16, 2026
Molecular characterization of pediatric mastocytosis revealed different somatic mutations with uncertain prognostic valueDeborah Kasmi, Fiorina Giona, Michela Ribersani, et al.
Expert Review of Hematology|June 14, 2021
Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature reviewFabio Efficace, Laura Cannella, Massimo Breccia, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 7, 2023
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New CompoundsEmilia Scalzulli, Ida Carmosino, Alessandro Costa, et al.
Seminars in Oncology|November 22, 2019
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology<sup>☆</sup>Massimo Breccia, Joseph R Carver, Sebastian Szmit, et al.
Oncology and Therapy|January 17, 2025
Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with RuxolitinibAlessandro Laganà, Emilia Scalzulli, Ida Carmosino, et al.
Critical Reviews in Oncology/Hematology|February 3, 2016
Do the smoking intensity and duration, the years since quitting, the methodological quality and the year of publication of the studies affect the results of the meta-analysis on cigarette smoking and Acute Myeloid Leukemia (AML) in adults?Vittoria Colamesta, Silvia D'Aguanno, Massimo Breccia, et al.
Expert Review of Hematology|December 8, 2024
Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in Chronic myeloid leukemia (CML)Alessandro Laganà, Emilia Scalzulli, Maria Laura Bisegna, et al.
Haematologica|September 5, 2007
Sustained molecular remission after low dose gemtuzumab-ozogamicin in elderly patients with advanced acute promyelocytic leukemiaMassimo Breccia, Giuseppe Cimino, Daniela Diverio, et al.
Pageof 43